TECH insider update: CFO RSUs vested, tax shares withheld
Rhea-AI Filing Summary
Bio-Techne (TECH) reported insider transactions by its CFO on 11/03/2025. The executive acquired company stock through RSU vesting and surrendered shares to cover taxes.
Two RSU conversions (code M) added 13,159 shares and 11,545 shares at $0. A tax withholding transaction (code F) disposed of 11,865 shares at $62.57. Following these transactions, the CFO directly owned 142,722 shares.
These actions reflect routine equity award vesting and associated tax settlement rather than an open‑market purchase or sale.
Positive
- None.
Negative
- None.
Insights
Routine RSU vesting with tax withholding; minimal impact.
The CFO reported equity award activity on 11/03/2025: RSUs vested (code M) adding 13,159 and 11,545 common shares at $0, and a tax withholding (code F) reduced holdings by 11,865 shares at $62.57.
Form 4 codes indicate non‑open‑market events tied to compensation. Such transactions generally do not signal changes in executive sentiment.
Post‑transaction holdings are 142,722 shares directly. Actual impact on float is minor and depends on award schedules and future vesting mechanics disclosed in the award footnotes.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 13,159 | $0.00 | -- |
| Exercise | Restricted Stock Units | 11,545 | $0.00 | -- |
| Exercise | Common Stock | 13,159 | $0.00 | -- |
| Exercise | Common Stock | 11,545 | $0.00 | -- |
| Tax Withholding | Common Stock | 11,865 | $62.57 | $742K |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Performance Restricted Stock Units | -- | -- | -- |
| holding | Performance Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Performance Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Performance Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
Footnotes (1)
- Fully exercisable. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026. 13,159 restricted stock units vest on 11/1/2025. Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). 4,010 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 4,011 restricted stock units vest on 8/15/2027. Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028. 11,545 restricted stock units vest on each of 11/1/2025 and 11/1/2026; and 11,544 restricted stock units vest on 11/1/2027. Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. Options to purchase 12,544 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
